About Syllable
Syllable is a company based in San Francisco (United States) founded in 2016 by Sarel Jooste and Adam Spanbauer. Syllable has raised $85.6 million across 4 funding rounds from investors including Verily, TCV and Oak HC/FT. Syllable has completed 1 acquisition, including Actium Health. Syllable offers products and services including Agent Builder, Prompt Editor, and Audio Channel Support. Syllable operates in a competitive market with competitors including Sensely, Vital, Loyal, Orbita and Aaron.ai, among others.
- Headquarter San Francisco, United States
- Founders Sarel Jooste, Adam Spanbauer
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stackbots Technology Private Limited
- Date of Incorporation 13 Oct, 2017
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$70.08 K (USD)-44.76as on Mar 31, 2022
-
Net Profit
$8.55 K (USD)-43.89as on Mar 31, 2022
-
EBITDA
$11.73 K (USD)-47.3as on Mar 31, 2022
-
Total Equity Funding
$85.6 M (USD)
in 4 rounds
-
Latest Funding Round
$40 M (USD), Series C
Apr 25, 2022
-
Investors
Verily
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Syllable
Syllable offers a comprehensive portfolio of products and services, including Agent Builder, Prompt Editor, and Audio Channel Support.
Platform for building voice AI agents for call centers.
Editor for creating and managing AI prompts easily.
System for handling voice calls via SIP or PSTN.
People of Syllable
Unlock access to complete
Unlock access to complete
Funding Insights of Syllable
Syllable has successfully raised a total of $85.6M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $40 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Syllable
Syllable has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Verily, TCV and Oak HC/FT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in global technology companies by TCV.
|
Locked | Locked | Locked | |
|
Investments are made in early-stage healthtech and fintech startups.
|
Locked | Locked | Locked | |
|
Tech startups are funded by S32, a venture capital entity.
|
Locked | Locked | Locked |
Investor details for Syllable
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Syllable
Syllable has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Actium Health.
Investment portfolio details for Syllable
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-powered marketing solutions are delivered for healthcare providers.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Syllable
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Syllable
Detailed financials for Syllable
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Syllable Comparisons
Peer comparison for Syllable
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Syllable
Syllable operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensely, Vital, Loyal, Orbita and Aaron.ai, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Conversational AI platforms are developed for enterprise healthcare and insurance.
|
|
| Locked | Locked | Locked |
Vital is recognized for patient experience technology in healthcare.
|
|
| Locked | Locked | Locked |
Loyal is recognized as a leading digital healthcare platform.
|
|
| Locked | Locked | Locked |
Conversational AI virtual assistants for healthcare patient engagement are provided.
|
|
| Locked | Locked | Locked |
Provider of AI-based speech recognition and natural language steering for Telephony
|
Detailed competitors of Syllable
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Syllable
Complete news archive for Syllable
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syllable
Syllable was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Syllable is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Kobus Jooste is the current CEO of Syllable.
Syllable is a funded company, having raised a total of $85.6M across 4 funding rounds to date.
Annual revenue of Syllable is $70.08K as on Mar 31, 2022.
Founded in 2016 and based in San Francisco, United States, Syllable operates in the healthcare AI sector. AI-driven tools, including the Voice Assistant, Web Assistant, and COVID-19 Vaccine Command Center, are developed for patient interactions. Natural language processing and machine learning models are utilized to deliver information and services through websites or mobile apps. Ontologies covering physician specialties, human diseases, and medical conditions are also maintained.
Syllable offers Agent Builder, Prompt Editor, and Audio Channel Support.
Syllable has made 1 acquisition, including Actium Health.